A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 199,676 shares of CDMO stock, worth $2.42 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
199,676
Previous 201,607 0.96%
Holding current value
$2.42 Million
Previous $3.86 Million 28.69%
% of portfolio
0.04%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $24,349 - $36,186
-1,931 Reduced 0.96%
199,676 $2.75 Million
Q3 2022

Nov 07, 2022

BUY
$15.33 - $20.36 $88,024 - $116,907
5,742 Added 2.93%
201,607 $3.86 Million
Q2 2022

Aug 09, 2022

BUY
$11.63 - $21.55 $650,640 - $1.21 Million
55,945 Added 39.98%
195,865 $2.99 Million
Q1 2022

May 13, 2022

BUY
$16.63 - $27.73 $2.33 Million - $3.88 Million
139,920 New
139,920 $2.85 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $755M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.